High-Risk IV Medications in Special Patient Populations

Author:   Sandra Kane-Gill ,  Joseph Dasta
Publisher:   Springer London Ltd
Edition:   2011 ed.
ISBN:  

9781447158684


Pages:   160
Publication Date:   15 August 2014
Format:   Paperback
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Our Price $343.17 Quantity:  
Add to Cart

Share |

High-Risk IV Medications in Special Patient Populations


Add your own review!

Overview

Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.

Full Product Details

Author:   Sandra Kane-Gill ,  Joseph Dasta
Publisher:   Springer London Ltd
Imprint:   Springer London Ltd
Edition:   2011 ed.
Dimensions:   Width: 15.50cm , Height: 1.50cm , Length: 23.50cm
Weight:   0.427kg
ISBN:  

9781447158684


ISBN 10:   1447158687
Pages:   160
Publication Date:   15 August 2014
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand   Availability explained
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Anesthetic agents (general, inhaled, intravenous).- Propofol, ketamine, etc.- Anti-infectives.- aminoglycosides, vancomycin, drotrecogin, amphotericin products.- inhaled agents.- Anticoagulants agents.- unfractionated heparin, low molecular weight heparins, fondaparinux, lepirudin, argatroban, bivalrudin, abciximab, eptifibatide, tirofiban.- Thrombolytics –reteplase, tenecteplase, streptokinase, urokinase, alteplase.- Cardiac Drugs.- Adrenergic agents.- dopamine, dobutamine, vasopressin, , nitroglycerin, nitroprusside epinephrine, norepinepherine, phenylepherine.- Adrenergic antagonists.- Propranolol, diltiazem, verapamil, esmolol, labetalol, clevidipine.- Antidyrrhthmics.- amiodarone, lidocaine, procainamide.- Inotropic agents.- milrinone, amrinone, isoproterenol, niseritide, digoxin.- Prostanoids.- Epoprostenol, iloprost, treprostenil.- Electrolytes.- Potassium, magnesium, sodium chloride (hypertonic), cardioplegic solutions.- Hypoglycemics.- Insulin and oral agents.- Neuromuscular blocking agents .- vecuronium, rocuronium, cisatracurium, atracurium, succinylcholine.- Opioids (IV, oral).- Remifentanyl, fentanyl , morphine, hydromorphone, meperidine.- Sedatives (IV, oral and transdermal).- lorazepam, midazolam, diazepam, propofol, dexmedetomidine.- Information for Each Drug.- Propofol .- Normal.- Obese.- Renal Dysfunction.- CrCL.- Dialysis (HD, CRRT).- Liver Dysfunction.- Recommendations for Safe Use.

Reviews

From the reviews: This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. ... It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. ... This is an excellent book that provides clear, concise information in a very usable format. --- (Judith Klevan, Doody's Review Service, November, 2011)


From the reviews: This book reviews the use of intravenous medications in patient populations with special considerations, discussing the dosing guidelines, safety concerns, and monitoring parameters. ... It is intended for clinicians treating critically ill patients with high-risk intravenous medications. This is a good reference for doctors, nurses, pharmacists, and students in these disciplines to use to become well versed in the safe use of dangerous medications. ... This is an excellent book that provides clear, concise information in a very usable format. (Judith Klevan, Doody's Review Service, November, 2011)


Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

Aorrng

Shopping Cart
Your cart is empty
Shopping cart
Mailing List